Evidence map›Paper›PMID 21690317›Full record

SynthesisNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2011

CHRNA3 rs1051730 genotype and short-term smoking cessation.

Marcus R Munafò, Elaine C Johnstone, Donna Walther, George R Uhl, Michael F G Murphy, Paul Aveyard

Registry-linked trialAbstract readMeta-AnalysisRandomized Controlled Trial
In one paragraph

Synthesis in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01780038 (Smokers' Response to Nicotine Dependence Genotyping), which is not on this map. Cited by 53 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01780038 nacompletednot on this mapstarted 2012, after this paper: background citation

Smokers' Response to Nicotine Dependence Genotyping

TypeinterventionalSponsorUniversity of NebraskaRan2012 to 2013Enrolled24ConditionsCigarette Smoking, Nicotine DependenceArmsReceipt of Genetic Results, No results given
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Low Smoking Exposure, the Adolescent Brain, and the Modulating Role of CHRNA5 Polymorphisms.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2019
    Article
  19. Association Between rs1051730 and Smoking During Pregnancy in Dutch Women.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcus R MunafòSchool of Experimental Psychology, University of Bristol, Bristol, UK. marcus.munafo@bristol.ac.uk
Elaine C Johnstone
Donna Walther
George R Uhl
Michael F G Murphy
Paul Aveyard

Funding

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: HumansZIADA000401 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$3.4M
Molecular Genetic Bases for Quit SuccessZIADA000537 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$2.9M
Cancer Research UK C53/A6281Intramural NIH HHS
6 · The paper itself

Abstract

introductionThe rs1051730 genetic variant within the CHRNA5-A3-B4 gene cluster is associated with heaviness of smoking and has recently been reported to be associated with likelihood of stopping smoking. We investigated the potential association of rs1051730 genotype with reduced likelihood of smoking cessation in 2 cohorts of treatment-seeking smokers in primary care in the United Kingdom.

methodsData were drawn from 2 clinical trials on which DNA was available. One sample was a randomized placebo-controlled trial of nicotine transdermal patch and the other sample an open-label trial where all participants received nicotine transdermal patch. Smoking status was biochemically verified. Logistic regression was used to assess evidence for association in each sample, and data were combined within a meta-analysis.

resultsThere was evidence of association of rs1051730 genotype with short-term (4-week) cessation in our open-label trial sample but not our placebo-controlled trial sample. When combined in a meta-analysis, this effect remained. There was no evidence of association at later follow-up intervals. Adjustment for cigarette consumption and tobacco dependence did not alter these results substantially.

conclusionsOur data, taken together with previous recent studies, provide some support for a weak association between this variant and short-term smoking cessation in treatment-seeking smokers, which does not seem to operate only among those receiving nicotine replacement therapy. Moreover, the rs1051730 variant may not merely operate as a marker for dependence or heaviness of smoking.

Indexed as

GenotypeAdolescentAdultAgedAllelesCarbon MonoxideCotinineDNAFollow-Up StudiesGenetic MarkersHumansLogistic ModelsMiddle AgedMultigene FamilyOdds RatioPolymorphism, Single NucleotideCarbon MonoxideCotinineDNAGenetic MarkersReceptors, Nicotinic

Identifiers

PMID21690317
PMCPMC3179672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.